DAIC

JANUARY 23, 2024

1,6 Until recently atherosclerosis has been thought of as the result of passive lipid accumulation in the vessel wall. However, the development of atherosclerosis is now known to be much more complex, with a key role for immune cells and inflammation in conjunction with hyperlipidemia and elevated LDL levels.7 Curr Opin Lipidol.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Dr. Paddy Barrett

JANUARY 23, 2024

Share While the average Western male and female will develop advanced coronary artery disease by age 55 and 66, respectively, 85% of the Tsimane tribe population over 40 had no evidence of advanced atherosclerosis 2. Coronary atherosclerosis, as evidenced by an abnormal CAC score, is a measure of advanced plaque. 2013 Jun;15(3):134-6.

Heart Disease 105

Heart Disease Blood Pressure Dementia Atherosclerosis 105

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

We conducted this study to identify fatigue subtypes in persons with prevalent HF in the ARIC study (Atherosclerosis Risk in Communities) and describe the distribution of characteristics across subtypes.Methods:We performed a cross-sectional analysis of 1065 participants with prevalent HF at ARIC visit 5 (2011–2013).

Atherosclerosis 40

Atherosclerosis Heart Failure Quality of Life Education 40

DAIC

MAY 29, 2024

Data presented today by AstraZeneca , at the European Atherosclerosis Society (EAS) Congress in France, on AZD0780, an oral PCSK9 inhibitor demonstrated significant LDL-C reduction on top of statin in Phase I trial. 2 ClinicalTrials.gov. 3 World Health Organization (WHO) [Internet]. Eur Heart J Qual Care Clin Outcomes. 2021;7(1):59-67.

Cholesterol 52

Cholesterol Cardiovascular Disease Atherosclerosis Myocardial Infarction 52

Stroke Journal

NOVEMBER 9, 2023

The observation period was divided into 4 epochs: 2008 to 2010, 2011 to 2013, 2014 to 2016, and 2017 to 2019. 56.2%), and statins for large artery atherosclerosis (76.1%–95.3%) in 2011–2013 and 2.3% men, 71.9%) were registered. Secondary prevention, including dual antiplatelets for noncardioembolic minor stroke (26.7%–47.0%),

Stroke 40

Stroke Strokes Outcomes Atrial Fibrillation 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. Descriptive statistics were used, summarizing continuous variables as means and standard deviations, and categorical variables as frequencies and ranges.ResultsBetween 2013 and 2022, 35 patients underwent intracranial stenting for symptomatic ICAS.

Stent 40

Stent Stents Outcomes Angioplasty 40

Stroke Journal

FEBRUARY 1, 2024

These microhemorrhages are a possible risk factor for ICH.Methods:A cohort of ARIC (Atherosclerosis Risk in Communities) participants underwent 3T MRI at visit 5 (2011-2013). CMBs result from irregularities in brain vessel structure due to chronic hypertension and cerebral amyloid angiopathy.

Hemorrhage 40

Hemorrhage Risk Factors Hypertension Atherosclerosis 40

Stroke Journal

JANUARY 30, 2025

This study aimed to investigate the association between L-HRV and WMH.Methods:The Atherosclerosis Risk in Communities (ARIC) study measured HRV using 2-minute readings in middle-aged adults at visit 4 conducted between 1996-1998 and conducted MRI scans during visit 5 between 2011-2013.

Atrial Fibrillation 40

Atrial Fibrillation Atherosclerosis Stroke Strokes 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundLipoprotein(a) is a possible causal risk factor for atherosclerosis and related complications. Journal of the American Heart Association, Ahead of Print. The distribution and prognostic implication of lipoprotein(a) in patients undergoing coronary artery bypass grafting remain unknown. The primary outcome was all‐cause death.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Coronary Artery Disease Atherosclerosis Risk Factors 40